4//SEC Filing
Henderson Jeffrey William 4
Accession 0001415889-25-000995
CIK 0001159036other
Filed
Jan 6, 7:00 PM ET
Accepted
Jan 7, 4:14 PM ET
Size
5.4 KB
Accession
0001415889-25-000995
Insider Transaction Report
Form 4
Henderson Jeffrey William
Director
Transactions
- Sale
Common Stock
2025-01-06$50.01/sh−10,000$500,060→ 43,611 total
Footnotes (2)
- [F1]The sale reported on this Form 4 was made pursuant to a written trading plan adopted by the Reporting Person on September 17, 2024 in accordance with Rule 10b5-1.
- [F2]Represents a weighted average sales price per share. The shares were sold at prices ranging from $50.00 to $50.11. The Reporting Person has provided to the issuer, and will provide to any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.
Documents
Issuer
HALOZYME THERAPEUTICS, INC.
CIK 0001159036
Entity typeother
Related Parties
1- filerCIK 0001324015
Filing Metadata
- Form type
- 4
- Filed
- Jan 6, 7:00 PM ET
- Accepted
- Jan 7, 4:14 PM ET
- Size
- 5.4 KB